cKK-E12 Ionizable Lipid is a synthetic, ionizable lipid designed for lipid nanoparticle (LNP) formulation and nucleic acid delivery research. Its pH-responsive ionizable amine groups support interactions with negatively charged nucleic acids and facilitate intracellular RNA delivery. Specifically, cKK-E12 has been investigated as a lipid component for small interfering RNA (siRNA) delivery and gene silencing applications. Additionally, its ionizable properties support the development of lipid-based delivery systems for RNA therapeutics, gene regulation, and nanomedicine research.
Key Features and Benefits
- Ionizable Lipid Structure: Features ionizable amine functionality that enables pH-dependent charge behavior for nucleic acid delivery applications.
- pH-Responsive Properties: Supports increased protonation under acidic conditions, while maintaining a lower positive charge at physiological pH depending on formulation characteristics.
- Lipid Nanoparticle Compatibility: Enables incorporation into multicomponent LNP formulations containing helper lipids, cholesterol, and PEG-lipids.
- RNA Delivery Capability: Supports encapsulation and intracellular delivery of suitable RNA molecules, particularly siRNA, through optimized lipid nanoparticle formulations.
- Endosomal Escape Potential: Specifically supports investigation of pH-responsive lipid interactions that may facilitate nucleic acid release from endosomal compartments.
- Nucleic Acid Encapsulation: Promotes electrostatic interactions with negatively charged RNA under suitable formulation conditions.
- Gene Silencing Applications: Supports development of siRNA-containing lipid nanoparticles for investigating RNA interference and gene expression regulation.
- Formulation Versatility: Enables optimization of lipid composition, particle size, encapsulation efficiency, and delivery performance in experimental systems.
- Nanomedicine Research Potential: Additionally, provides a functional lipid component for investigating RNA delivery technologies and advanced nucleic acid therapeutics.
Applications
- Lipid Nanoparticle Formulation: Supports preparation of ionizable lipid nanoparticles for nucleic acid encapsulation and delivery research.
- siRNA Delivery Research: Enables development of lipid-based carriers for intracellular delivery of small interfering RNA.
- RNA Interference Studies: Facilitates investigation of sequence-specific gene silencing through siRNA-mediated regulation of gene expression.
- mRNA Delivery Research: Supports exploratory development of mRNA-containing lipid nanoparticles, although performance requires formulation-specific validation.
- Gene Delivery Research: Specifically enables investigation of lipid-mediated nucleic acid delivery and intracellular transport mechanisms.
- Endosomal Escape Studies: Supports research into pH-responsive lipid behavior and intracellular nucleic acid release.
- LNP Formulation Optimization: Enables evaluation of lipid ratios, particle size, surface characteristics, and RNA encapsulation efficiency.
- Cellular Uptake Research: Additionally, supports investigation of nanoparticle internalization, intracellular trafficking, and nucleic acid delivery efficiency.
- Nanomedicine Development: Provides an ionizable lipid building block for developing experimental RNA delivery platforms and nucleic acid-based therapeutic formulations.
Storage and Handling
- Storage: Store at −20°C in a dry, tightly sealed container, protected from moisture, light, and heat. Additionally, minimize temperature fluctuations to preserve lipid integrity.
- Handling: Use clean, dry equipment and appropriate protective gear. Prepare solutions in compatible organic solvents, such as ethanol or DMSO, after confirming solubility.
- Nanoparticle Preparation: Combine with suitable helper lipids, cholesterol, and PEG-lipids using compatible LNP formulation methods. Subsequently, optimize lipid ratios, mixing conditions, and RNA loading efficiency.
- Formulation and Analysis: Evaluate nanoparticle size, polydispersity, encapsulation efficiency, and RNA integrity using appropriate analytical methods. Additionally, assess cellular uptake, delivery efficiency, and cytotoxicity under validated experimental conditions.
cKK-E12 Ionizable Lipid combines pH-responsive ionization with nucleic acid delivery functionality for lipid nanoparticle research. Its chemical properties support RNA encapsulation, intracellular transport, and investigation of endosomal release mechanisms. Therefore, it provides a useful lipid component for siRNA delivery, gene silencing, LNP formulation optimization, and advanced nanomedicine research.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
